fluorodeoxyuridylate has been researched along with oligonucleotides in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berger, A; Busch, C; Garbe, C; Ikenberg, K; Meier, F; Niessner, H; Schott, S; Sinnberg, T; Venturelli, S; Villanueva, J | 1 |
| Armeanu-Ebinger, S; Dewerth, A; Eicher, C; Ellerkamp, V; Fuchs, J; Schott, S | 1 |
2 other study(ies) available for fluorodeoxyuridylate and oligonucleotides
| Article | Year |
|---|---|
Cytotoxicity of new duplex drugs linking 3'-C-ethynylcytidine and 5-fluor-2'-deoxyuridine against human melanoma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Chick Embryo; Cytidine; Cytidine Monophosphate; Drug Discovery; Drug Screening Assays, Antitumor; Floxuridine; Fluorodeoxyuridylate; Humans; Indoles; Melanoma; Mice; Mice, Nude; Oligonucleotides; Random Allocation; Sulfonamides; Vemurafenib; Xenograft Model Antitumor Assays | 2012 |
Effect of duplex drugs linking 2'-deoxy-5-fluorouridine (5-FdU) with 3'-C-ethynylcytidine (ECyd) on hepatoblastoma cell lines.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cytidine Monophosphate; Flow Cytometry; Fluorodeoxyuridylate; Hepatoblastoma; Humans; Liver Neoplasms; Oligonucleotides; Tumor Cells, Cultured | 2013 |